Jessica M Koontz-ferrera, LCSW-C | |
49 Rock Springs Rd, Conowingo, MD 21918-1352 | |
(410) 378-9696 | |
(410) 378-9922 |
Full Name | Jessica M Koontz-ferrera |
---|---|
Gender | Female |
Speciality | Clinical Social Worker |
Experience | 7 Years |
Location | 49 Rock Springs Rd, Conowingo, Maryland |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679247878 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 23315 (Maryland) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
West Cecil Health Center Inc | 6709964398 | 18 |
News Archive
Odyssey Thera, Inc. announced that it will receive milestone payments from one of its investors, Pfizer Inc. following Pfizer's decision to progress drug candidates studied by Odyssey Thera as part of Odyssey's multi-year alliance with Pfizer announced in August, 2006.
Affiliated Computer Services, Inc. (ACS), A Xerox Company, today announced a definitive agreement to acquire CredenceHealth, Inc., creating a simple way for healthcare providers to use patient information to predict and prevent complications.
ImmunoCellular Therapeutics, Ltd., a clinical stage biotechnology company that is focused on developing new immune-based products to treat cancer, announced today that it will expand its current Phase IIb trial of ICT-107 from 102 to up to 123 patients with glioblastoma multiforme (GBM) and who are HLA-A1/A2 positive.
Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening with high-risk patients because of a high rate of false positives and other factors, those conversations aren't happening the way they should be, according to a study by researchers from the University of North Carolina Lineberger Comprehensive Cancer Center.
› Verified 1 days ago
Entity Name | Della Behavioral Health Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750635207 PECOS PAC ID: 3971755000 Enrollment ID: O20121218000204 |
News Archive
Odyssey Thera, Inc. announced that it will receive milestone payments from one of its investors, Pfizer Inc. following Pfizer's decision to progress drug candidates studied by Odyssey Thera as part of Odyssey's multi-year alliance with Pfizer announced in August, 2006.
Affiliated Computer Services, Inc. (ACS), A Xerox Company, today announced a definitive agreement to acquire CredenceHealth, Inc., creating a simple way for healthcare providers to use patient information to predict and prevent complications.
ImmunoCellular Therapeutics, Ltd., a clinical stage biotechnology company that is focused on developing new immune-based products to treat cancer, announced today that it will expand its current Phase IIb trial of ICT-107 from 102 to up to 123 patients with glioblastoma multiforme (GBM) and who are HLA-A1/A2 positive.
Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening with high-risk patients because of a high rate of false positives and other factors, those conversations aren't happening the way they should be, according to a study by researchers from the University of North Carolina Lineberger Comprehensive Cancer Center.
› Verified 1 days ago
Entity Name | West Cecil Health Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366625089 PECOS PAC ID: 6709964398 Enrollment ID: O20140318000266 |
News Archive
Odyssey Thera, Inc. announced that it will receive milestone payments from one of its investors, Pfizer Inc. following Pfizer's decision to progress drug candidates studied by Odyssey Thera as part of Odyssey's multi-year alliance with Pfizer announced in August, 2006.
Affiliated Computer Services, Inc. (ACS), A Xerox Company, today announced a definitive agreement to acquire CredenceHealth, Inc., creating a simple way for healthcare providers to use patient information to predict and prevent complications.
ImmunoCellular Therapeutics, Ltd., a clinical stage biotechnology company that is focused on developing new immune-based products to treat cancer, announced today that it will expand its current Phase IIb trial of ICT-107 from 102 to up to 123 patients with glioblastoma multiforme (GBM) and who are HLA-A1/A2 positive.
Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening with high-risk patients because of a high rate of false positives and other factors, those conversations aren't happening the way they should be, according to a study by researchers from the University of North Carolina Lineberger Comprehensive Cancer Center.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Jessica M Koontz-ferrera, LCSW-C Po Box 307, Simpsonville, MD 21150-0307 Ph: (443) 545-9027 | Jessica M Koontz-ferrera, LCSW-C 49 Rock Springs Rd, Conowingo, MD 21918-1352 Ph: (410) 378-9696 |
News Archive
Odyssey Thera, Inc. announced that it will receive milestone payments from one of its investors, Pfizer Inc. following Pfizer's decision to progress drug candidates studied by Odyssey Thera as part of Odyssey's multi-year alliance with Pfizer announced in August, 2006.
Affiliated Computer Services, Inc. (ACS), A Xerox Company, today announced a definitive agreement to acquire CredenceHealth, Inc., creating a simple way for healthcare providers to use patient information to predict and prevent complications.
ImmunoCellular Therapeutics, Ltd., a clinical stage biotechnology company that is focused on developing new immune-based products to treat cancer, announced today that it will expand its current Phase IIb trial of ICT-107 from 102 to up to 123 patients with glioblastoma multiforme (GBM) and who are HLA-A1/A2 positive.
Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening with high-risk patients because of a high rate of false positives and other factors, those conversations aren't happening the way they should be, according to a study by researchers from the University of North Carolina Lineberger Comprehensive Cancer Center.
› Verified 1 days ago
Dawn Marie Gomez, MSW, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 151 Rock Springs Rd, Conowingo, MD 21918 Phone: 800-491-5369 Fax: 301-774-3678 | |
Amanda Page, LCSW- C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 49 Rock Springs Rd, Conowingo, MD 21918 Phone: 410-378-9696 Fax: 410-378-9922 | |
April C Hopkins, LCSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 49 Rock Springs Rd, Conowingo, MD 21918 Phone: 410-378-9696 Fax: 410-378-9922 | |
Jan Marie Brewer, LCSW-C Clinical Social Worker Medicare: May Accept Medicare Assignments Practice Location: 49 Rock Springs Rd, Conowingo, MD 21918 Phone: 410-378-9696 Fax: 410-378-9922 | |
Karen Glab-bivens, LCSW-C Clinical Social Worker Medicare: May Accept Medicare Assignments Practice Location: 49 Rock Springs Rd, Conowingo, MD 21918 Phone: 410-378-9696 Fax: 410-378-9922 | |
Rachel Dawn Priebe, LCSW-C Clinical Social Worker Medicare: May Accept Medicare Assignments Practice Location: 49 Rock Springs Rd, Conowingo, MD 21918 Phone: 410-378-9696 Fax: 410-378-9922 | |
Sarah Reiman, LCSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 49 Rock Springs Rd, Conowingo, MD 21918 Phone: 443-731-2987 |